Skip to main content

Hypoglycemia

  • Reference work entry
  • First Online:

Part of the book series: Endocrinology ((ENDOCR))

Abstract

Hypoglycemia rarely exists in humans outside diabetes mellitus treated with insulin and/or sulfonylureas. Because hypoglycemia produces marked discomfort, lasting for hours, and may progress to severe neuroglycopenia with cognitive dysfunction, unconsciousness, sometimes even epilepsy, hypoglycemia is highly feared by patients. Hypoglycemia may increase the cardiovascular risk of affected and/or elderly patients and is long-term associated with risk of dementia. In type 1 diabetes and also in those type 2 patients who lose β-cell function nearly totally, there is impaired response of glucagon to hypoglycemia which predisposes to a higher risk for hypoglycemia. In turn, recurrent hypoglycemia results in brain adaptation with loss of other counterregulatory hormones, primarily adrenaline, and symptom responses (hypoglycemia unawareness). This creates a vicious circle which predisposes to severe hypoglycemia. However, prevention of hypoglycemia in patients with hypoglycemia unawareness may recover both hormonal and symptoms responses to hypoglycemia thus reducing the risk for severe hypoglycemia. Prevention of hypoglycemia is therefore a key issue in insulin treatment. Education of patients, use of modern SMPG and CGM systems, harmonization of rapid-acting and long-acting analogues of insulin (in place of human insulin) reduce the risk for hypoglycemia. To reduce the risk for hypoglycemia in type 2 diabetes, basal should be preferred to prandial insulin. If postprandial hyperglycemia requires treatment, GLP-1RAs should be added in place of prandial insulin whenever possible. In addition, sulfonylureas should not be initiated and withdrawn if in use, and DPP-IV started instead. The optimal treatment of diabetes is the combination of an A1C level individualized for the personal characteristics of the patient and minimal risk for hypoglycemia.

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   329.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  • Abraira C, Henderson W, Colwell J, VA CSDM Group, et al. Response to intensive therapy steps and to glipizide dose in combination with insulin in type 2 diabetes (VA feasibility study). Diabetes Care. 1998;21:574–9.

    Article  CAS  PubMed  Google Scholar 

  • ADA. Standards of medical care in diabetes – 2008. Diabetes Care. 2008;31(Suppl 1):S12–54.

    Google Scholar 

  • Adler GK, Bonyhay I, Failing H, Waring E, Dotson S, Freeman R. Antecedent hypoglycemia impairs autonomic cardiovascular function: implications for rigorous glycemic control. Diabetes. 2009;58:360–6.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • American Diabetes Association. Standards of medical care in diabetes 2018. Diabetes Care. 2005;41(Suppl 1):S55–64.

    Google Scholar 

  • Arbelaez AM, Xing D, Cryer PE, Kollman C, Beck RW, Sherr J, Ruedy KJ, Tamborlane WV, Mauras N, Tsalikian E, Wilson DM, White NH, Diabetes Research in Children Network (DirecNet) Study Group. Blunted glucagon but not epinephrine responses to hypoglycemia occurs in youth with less than 1 yr duration of type 1 diabetes mellitus. Pediatr Diabetes. 2014;15:127–34.

    Article  CAS  PubMed  Google Scholar 

  • Bain S, Druyts E, Balijepalli C, Baxter CA, Currie CJ, Das R, Donnelly R, Khunti K, Langerman H, Leigh P, Siliman G, Thorlund K, Toor K, Vora J, Mills EJ. Cardiovascular events and all-cause mortality associated with sulfonylureas compared with other antihyperglycaemic drugs: a Bayesian meta-analysis of survival data. Diabetes Obes Metab. 2017;19:329–35.

    Article  CAS  PubMed  Google Scholar 

  • Banarer S, Cryer PE. Sleep-related hypoglycemia-associated autonomic failure in type 1 diabetes: reduced awakening from sleep during hypoglycemia. Diabetes. 2003;52:1195–203.

    Article  CAS  PubMed  Google Scholar 

  • Banarer S, McGregor VP, Cryer PE. Intraislet hyperinsulinemia prevents the glucagon response to hypoglycemia despite an intact autonomic response. Diabetes. 2002;51:958–65.

    Article  CAS  PubMed  Google Scholar 

  • Barranco RJ, Gomez-Peralta F, Abreu C, Delgado M, Palomares R, et al. Incidence and care-related costs of severe hypoglycemia requiring emergency treatment in Andalusia (Spain): the PAUEPAD project. Diabet Med. 2015;32:1520–6.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Battelino T, Phillip M, Bratina N, Nimri R, Oskarsson P, Bolinder J. Effect of continuous glucose monitoring on hypoglycemia in type 1 diabetes. Diabetes Care. 2011;34:795–800.

    Article  PubMed  PubMed Central  Google Scholar 

  • Battelino T, Nimri R, Dovc K, Phillip M, Bratina N. Prevention of hypoglycemia with predictive low glucose insulin suspension in children with type 1 diabetes: a randomized controlled trial. Diabetes Care. 2017;40:764–770.

    Article  CAS  PubMed  Google Scholar 

  • Beall C, Hamilton DL, Gallagher J, Logie L, Wright K, Soutar MP, Dadak S, Ashford FB, Haythorne E, Du Q, Jovanović A, McCrimmon RJ, Ashford ML. Mouse hypothalamic GT1-7 cells demonstrate AMPK-dependent intrinsic glucose-sensing behaviour. Diabetologia. 2012;55:2432–44.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Bolli GB. From physiology of glucose counterregulation to prevention of hypoglycemia in type 1 diabetes mellitus. Diabetes Nutr Metab. 1990;4:333–49.

    Google Scholar 

  • Bolli GB, Fanelli CG. Physiology of glucose counterregulation to hypoglycemia. Endocrinol Metab Clin N Am. 1999;28:467–93.

    Article  CAS  Google Scholar 

  • Bolli GB, De Feo P, De Cosmo S, Perriello G, Ventura MM, Benedetti MM, Santeusanio F, Gerich JE, Brunetti P. A reliable and reproducible test for adequate glucose counterregulation in type I diabetes mellitus. Diabetes. 1984a;33:732–7.

    Article  CAS  PubMed  Google Scholar 

  • Bolli GB, Dimitriadis GD, Pehling GB, Baker BA, Haymond MW, Cryer PE, Gerich JE. Abnormal glucose counterregulation after subcutaneous insulin in insulin-dependent diabetes mellitus. N Engl J Med. 1984b;310:1706–11.

    Article  CAS  PubMed  Google Scholar 

  • Bolli GB, Porcellati F, Lucidi P, Fanelli CG. Glucose control in diabetes: targets and therapy. In: Bruttomesso D, Grassi G (eds): Technological advances in the treatment of type 1 diabetes. Front Diabetes. Basel, Karger, 2015, vol 24, pp 1–10.

    Google Scholar 

  • Borg MA, Sherwin RS, Borg WP, Tamborlane WV, Shulman GI. Local ventromedial hypothalamus glucose perfusion blocks counterregulation during systemic hypoglycemia in awake rats. J Clin Invest. 1997;99:361–5.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Boyle PJ, Schwartz NS, Shah SD, Clutter WE, Cryer PE. Plasma glucose concentrations at the onset of hypoglycemic symptoms in patients with poorly controlled diabetes and in nondiabetics. N Engl J Med. 1988;318:1487–92.

    Article  CAS  PubMed  Google Scholar 

  • Boyle PJ, Kempers SF, O’Connor AM, Nagy RJ. Brain glucose uptake and unawareness of hypoglycemia in patients with insulin dependent diabetes mellitus. N Engl J Med. 1995;333:1726–31.

    Article  CAS  PubMed  Google Scholar 

  • Bramlage P, Gitt AK, Binz C, Krekler M, Deeg E, Tschöpe D. Oral antidiabetic treatment in type-2 diabetes in the elderly: balancing the need for glucose control and the risk of hypoglycemia. Cardiovasc Diabetol. 2012;11:122.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Bremer JP, Jauch-Chara K, Hallschmid M, Schmid S, Schultes B. Hypoglycemia unawareness in older compared with middle-aged patients with type 2 diabetes. Diabetes Care. 2009;32:1513–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Brunkhorst FM, Engel C, Bloos F, Meier-Hellmann A, Ragaller M, Weiler N, Moerer O, Gruendling M, Oppert M, Grond S, Olthoff D, Jaschinski U, John S, Rossaint R, Welte T, Schaefer M, Kern P, Kuhnt E, Kiehntopf M, Hartog C, Natanson C, Loeffler M, Reinhart K. Intensive insulin therapy and pentastarch resuscitation in severe sepsis. N Engl J Med. 2008;358:125–39.

    Article  CAS  PubMed  Google Scholar 

  • Cahill GF Jr, Herrera MG, Morgan AP, et al. Hormone-fuel interrelationship during fasting. J Clin Invest. 1966;45:1751–69.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Cahill GF Jr. Starvation in man. N Engl J Med. 1970;282:668–75.

    Article  CAS  PubMed  Google Scholar 

  • Capes SE, Hunt D, Malmberg K, Gerstein HC. Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview. Lancet. 2000;355:773–8.

    Article  CAS  PubMed  Google Scholar 

  • Cersosimo E, Judd RL, Miles JM. Insulin regulation of renal glucose metabolism in conscious dogs. J Clin Invest. 1994;93:2584–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Cersosimo E, Molina PE, Abumrad NN. Renal glucose production during insulin-induced hypoglycemia. Diabetes. 1997;46:643–6.

    Article  CAS  PubMed  Google Scholar 

  • Cersosimo E, Garlick P, Ferretti J. Insulin regulation of renal glucose metabolism in humans. Am J Phys. 1999a;276:E78–84.

    CAS  Google Scholar 

  • Cersosimo E, Garlick P, Ferretti J. Renal glucose production during insulin-induced hypoglycemia in humans. Diabetes. 1999b;48:261–6.

    Article  CAS  PubMed  Google Scholar 

  • Chan O, Sherwin R. Influence of VMH fuel sensing on hypoglycemic responses. Trends Endocrinol Metab. 2013;24:616–24.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Choi IY, Gruetter R. In vivo 13C NMR assessment of brain glycogen concentration and turnover in the awake rat. Neurochemistry International. 2003;43(4–5):317–322.

    Article  CAS  PubMed  Google Scholar 

  • Choudhary P, Shin J, Wang Y, Evans ML, Hammond PJ, Kerr D, Shaw JA, Pickup JC, Amiel SA. Insulin pump therapy with automated insulin suspension in response to hypoglycemia: reduction in nocturnal hypoglycemia in those at greatest risk. Diabetes Care. 2011;34:2023–5.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Choudhary P, Ramasamy S, Green L, Gallen G, Pender S, Brackenridge A, Amiel SA, Pickup JC. Realtime continuous glucose monitoring significantly reduces severe hypoglycemia in hypoglycemia unaware patients with type 1 diabetes. Diabetes Care. 2013;36:4160–2.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Choudhary P, Olsen BS, Conget I, Welsh JB, Vorrink L, Shin JJ. Hypoglycemia prevention and user acceptance of an insulin pump system with predictive low glucose management. Diabetes Technol Ther. 2016;18:288–291.

    Article  CAS  Google Scholar 

  • Chraibi A, Hasna A. The cost of hypoglycemia. In: Hypoglycemia-causes and occurrences. 2016. ISBN: 978-1-944685-80-5, 1-4. Downloadable at: http://www.smgebooks.com/hypoglycemia-causes-occurrences/chapters/HG-16-02.pdf.

  • Clarke DD, Sokoloff L. Circulation and energy metabolism of the brain. In: Siegel GJ, et al., editors. Basic neurochemistry: molecular, cellular and medical aspects. 5th ed. New York: Raven Press; 1994. p. 645–52.

    Google Scholar 

  • Coiro V, Volpi R, Cataldo S, Magotti MG, Giumelli C, Russo F, Stella A, Chiodera P. Glucoreceptors located in the brain mediate NPY release induced by hypoglycemia in normal men. Regul Pept. 2011;172:41–3.

    Article  CAS  PubMed  Google Scholar 

  • Cox DJ, Gonder-Frederick L, Julian DM, Clarke W. Long-term follow-up evaluation of blood glucose awareness training. Diabetes Care. 1994;17:1–5.

    Article  CAS  PubMed  Google Scholar 

  • Cox D, Gonder-Frederick L, Polonsky W, Schlundt D, Julian D, Clarke W. A multicenter evaluation of blood glucose awareness training-II. Diabetes Care. 1995;18:523–8.

    Article  CAS  PubMed  Google Scholar 

  • Cranston I, Lomas J, Maran A, Macdonald I, Amiel SA. Restoration of hypoglycemia awareness in patients with long-duration insulin-dependent diabetes. Lancet. 1994;344:283–7.

    Article  CAS  PubMed  Google Scholar 

  • Cryer PE. Iatrogenic hypoglycemia as a cause of hypoglycemia-associated autonomic failure in IDDM. A vicious cycle. Diabetes. 1992;41:255–60.

    Article  CAS  PubMed  Google Scholar 

  • Cryer PE. Hypoglycemia-associated autonomic failure in diabetes. Am J Phys. 2001;281:E1115–21.

    CAS  Google Scholar 

  • Cryer PE. Diverse causes of hypoglycemia-associated autonomic failure in diabetes. N Engl J Med. 2004;350:2272–9.

    Article  CAS  PubMed  Google Scholar 

  • Cryer PE. Mechanisms of hypoglycemia-associated autonomic failure and its component syndromes in diabetes. Diabetes. 2005;54:3592–601.

    Article  CAS  PubMed  Google Scholar 

  • Cryer PE. Exercise-related hypoglycemia-associated autonomic failure in diabetes. Diabetes. 2009;58:1951–2.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Cryer PE. Mechanisms of hypoglycemia-associated autonomic failure in diabetes. N Engl J Med. 2013;369:362–72.

    Article  CAS  PubMed  Google Scholar 

  • Cryer PE. Hypoglycemia in diabetes: pathophysiology, prevalence, and prevention. 3rd ed. Alexandria: American Diabetes Association; 2016. p. 3–8.

    Google Scholar 

  • Cryer PE, Davis SN, Shamoon HS. Hypoglycemia in diabetes. Diabetes Care. 2003;26:1902–12.

    Article  CAS  PubMed  Google Scholar 

  • Curkendall SM, Natoli JL, Alexander CM, Nathanson BH, Haidar T, et al. Economic and clinical impact of inpatient diabetic hypoglycemia. Endocr Pract. 2009;15:302–12.

    Article  PubMed  Google Scholar 

  • Dagogo-Jack S. Philip E. Cryer, MD: seminal contributions to the understanding of hypoglycemia and glucose counterregulation and the discovery of HAAF (Cryer syndrome). Diabetes Care. 2015;38:2193–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Dagogo-Jack SE, Cryer PE. Hypoglycemia-associated autonomic failure in insulin-dependent diabetes mellitus. Recent antecedent hypoglycemia reduces autonomic responses to, symptoms of, and defense against subsequent hypoglycemia. J Clin Invest. 1993;91:819–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Dagogo-Jack S, Rattarasarn C, Cryer PE. Reversal of hypoglycemia unawareness, but not defective glucose counterregulation, in IDDM. Diabetes. 1994;43:1426–34.

    Article  CAS  PubMed  Google Scholar 

  • Dagogo-Jack S, Fanelli CG, Cryer PE. Durable reversal of hypoglycemia unawareness in type 1 diabetes. Diabetes Care. 1999;22:866–7.

    Article  CAS  PubMed  Google Scholar 

  • Dalsgaard-Nielsen J, Madsbad S, Hilsted J. Changes in platelet function, blood coagulation and fibrinolysis during insulin-induced hypoglycemia in juvenile diabetics and normal subjects. Thromb Haemost. 1982;47:254–8.

    Article  CAS  PubMed  Google Scholar 

  • DCCT Research Group. Epidemiology of severe hypoglycemia in the diabetes control and complications trial. The DCCT Research Group. Am J Med. 1991;90:450–9.

    Article  Google Scholar 

  • De Feo P, Perriello G, De Cosmo S, et al. Comparison of glucose counterregulation during short-term and prolonged hypoglycemia in normal humans. Diabetes. 1986;35:563–9.

    Article  PubMed  Google Scholar 

  • de Galan BE, Zoungas S, Chalmers J, Anderson C, Dufouil C, Pillai A, Cooper M, Grobbee DE, Hackett M, Hamet P, Heller SR, Lisheng L, Macmahon S, Mancia G, Neal B, Pan CY, Patel A, Poulter N, Travert F, Woodward M, ADVANCE Collaborative Group. Cognitive function and risks of cardiovascular disease and hypoglycemia in patients with type 2 diabetes: the action in diabetes and vascular disease: Preterax and Diamicron Modified Release Controlled Evaluation (ADVANCE) trial. Diabetologia. 2009;52:2328–36.

    Article  PubMed  CAS  Google Scholar 

  • de Zoysa N, Rogers H, Stadler M, Gianfrancesco C, Beveridge S, Britneff E, Choudhary P, Elliott J, Heller S, Amiel SA. A psychoeducational program to restore hypoglycemia awareness: the DAFNE-HART pilot study. Diabetes Care. 2014;37:863–6.

    Article  PubMed  Google Scholar 

  • DeRosa MA, Cryer PE. Hypoglycemia and the sympathoadrenal system: neurogenic symptoms are largely the result of sympathetic neural, rather than adrenomedullary, activation. Am J Physiol Endocrinol Metab. 2004;287:E32–41.

    Article  CAS  PubMed  Google Scholar 

  • Desouza C, Salazar H, Cheong B, Murgo J, Fonseca V. Association of hypoglycemia and cardiac ischemia: a study based on continuous monitoring. Diabetes Care. 2003;26:1485–9.

    Article  PubMed  Google Scholar 

  • Desouza CV, Bolli GB, Fonseca V. Hypoglycemia, diabetes, and cardiovascular events. Diabetes Care. 2010;33:1389–94.

    Article  PubMed  PubMed Central  Google Scholar 

  • Di Rocco R, Grill H. The forebrain is not essential for sympathoadrenal hyperglycemic response to glucoprivation. Science. 1979;204:1112–4.

    Article  Google Scholar 

  • Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study Research Group, Jacobson AM, Musen G, Ryan CM, Silvers N, Cleary P, Waberski B, Burwood A, Weinger K, Bayless M, Dahms W, Harth J. Long-term effect of diabetes and its treatment on cognitive function. N Engl J Med. 2007;356:1842–52.

    Article  Google Scholar 

  • Donovan CM, Watts AG. Peripheral and central glucose sensing in hypoglycemic detection. Physiology (Bethesda). 2014;29:314–24.

    CAS  Google Scholar 

  • Duckworth W, Abraira C, Moritz T, Reda D, Emanuele N, Reaven PD, Zieve FJ, Marks J, Davis SN, Hayward R, Warren SR, Goldman S, McCarren M, Vitek ME, Henderson WG, Huang GD. Glucose control and vascular complications in veterans with type 2 diabetes. N Engl J Med. 2009;360:129–39.

    Article  CAS  PubMed  Google Scholar 

  • Egeli ES, Berkmen R. Action of hypoglycemia on coronary insufficiency and mechanism of ECG alterations. Am Heart J. 1960;59:527–40.

    Article  CAS  PubMed  Google Scholar 

  • EMA. Guideline on clinical investigation of medicinal products in the treatment or prevention of diabetes mellitus. European Medicine Agency. 2012. Accessed 1 Feb 2017.

    Google Scholar 

  • Evans ML, McCrimmon RJ, Flanagan DE, Keshavarz T, Fan X, McNay EC, Jacob RJ, Sherwin RS. Hypothalamic ATP-sensitive K + channels play a key role in sensing hypoglycemia and triggering counterregulatory epinephrine and glucagon responses. Diabetes. 2004;53:2542–51.

    Article  CAS  PubMed  Google Scholar 

  • Fanelli C, Epifano L, Rambotti A, Pampanelli S, Di Vincenzo A, Modarelli F, Lepore M, Ciofetta M, Bottini P, Porcellati F, Scionti L, Santeusanio F, Brunetti P, Bolli GB. Meticulous prevention of hypoglycemia normalizes the glycemic thresholds and magnitude of most of neuroendocrine responses to, symptoms of, and cognitive function during hypoglycemia in intensively treated patients with short-term IDDM. Diabetes. 1993a;42:1683–9.

    Article  CAS  PubMed  Google Scholar 

  • Fanelli C, Calderone S, Epifano L, De Vincenzo A, Modarelli F, Pampanelli S, Perriello G, De Feo P, Brunetti P, Gerich JE, Bolli GB. Demonstration of a critical role for free fatty acids in mediating counterregulatory stimulation of gluconeogenesis and suppression of glucose utilization in humans. J Clin Invest. 1993b;92:1617–22.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Fanelli C, Pampanelli S, Epifano L, Rambotti AM, Di Vincenzo A, Modarelli F, Ciofetta M, Lepore M, Annibale B, Torlone E, Perriello G, De Feo P, Santeusanio F, Brunetti P, Bolli GB. Long-term recovery from unawareness, deficient counterregulation and lack of cognitive dysfunction during hypoglycemia, following institution of rational, intensive insulin therapy in IDDM. Diabetologia. 1994a;37:1265–76.

    Article  CAS  PubMed  Google Scholar 

  • Fanelli C, Pampanelli S, Epifano L, Rambotti AM, Ciofetta M, Modarelli F, Di Vincenzo A, Annibale B, Lepore M, Lalli C, Del Sindaco P, Brunetti P, Bolli GB. Relative roles of insulin and hypoglycemia on induction of neuroendocrine responses to, symptoms of, and deterioration of cognitive function in hypoglycemia in male and female humans. Diabetologia. 1994b;37:797–807.

    Article  CAS  PubMed  Google Scholar 

  • Fanelli C, Pampanelli S, Lalli C, Del Sindaco P, Ciofetta M, Lepore M, Porcellati F, Bottini P, Di Vincenzo A, Brunetti P, Bolli GB. Long-term intensive therapy of IDDM diabetic patients with clinically overt autonomic neuropathy: effects on awareness of, and counterregulation to hypoglycemia. Diabetes. 1997;46:1172–81.

    Article  CAS  PubMed  Google Scholar 

  • Fanelli CG, Paramore DS, Hershey T, et al. Impact of nocturnal hypoglycemia on hypoglycemic cognitive dysfunction in type 1 diabetes. Diabetes. 1998;47:1920–7.

    Article  CAS  PubMed  Google Scholar 

  • Fanelli CG, Pampanelli S, Porcellati F. Cognitive function in hypoglycemia. Diabetes Nutr Metab. 2002;15:367–72.

    CAS  PubMed  Google Scholar 

  • FDA Guidance for industry Diabetes Mellitus: developing drugs and therapeutic biologics for treatment and prevention, 2008. http://www.fda.gov/downloads/Drugs/Guidances/ucm071624.pdf. Accessed 1 Feb 2017.

  • Finfer S, Chittock DR, Su SY, Blair D, Foster D, Dhingra V, Bellomo R, Cook D, Dodek P, Henderson WR, Hebert PC, Heritier S, Heyland DK, McArthur C, McDonald E, Mitchell I, Myburgh JA, Norton R, Potter J, Robinson BG, Ronco JJ. Intensive versus conventional glucose control in critically ill patients. N Engl J Med. 2009;360:1283–97.

    Article  PubMed  Google Scholar 

  • Fisher BM, Hepburn DA, Smith JG, Frier BM. Responses of peripheral blood cells to acute insulin-induced hypoglycemia in humans: effect of alpha-adrenergic blockade. Horm Metab Res Suppl. 1992;26:109–10.

    CAS  PubMed  Google Scholar 

  • Fisman EZ, Motro M, Tenenbaum A, Leor J, Boyko V, Mandelzweig L, Sherer Y, Adler Y, Behar S. Is hypoglycemia a marker for increased long-term mortality risk in patients with coronary artery disease? An 8-year follow-up. Eur J Cardiovasc Prev Rehabil. 2004;11:135–43.

    Article  PubMed  Google Scholar 

  • Foos V, Varol N, Curtis BH, Boye KS, Grant D, Palmer JL, McEwan P. Economic impact of severe and non-severe hypoglycemia in patients with type 1 and type 2 diabetes in the United States. J Med Econ. 2015;18:420–32.

    Article  PubMed  Google Scholar 

  • Frier BM. The economic costs of hypoglycemia. Br J Diabetes Vasc Dis. 2011;11(Suppl 1):S10–2.

    Article  Google Scholar 

  • Fritsche A, Stefan N, Häring H, Gerich J, Stumvoll M. Avoidance of hypoglycemia restores hypoglycemia awareness by increasing beta-adrenergic sensitivity in type 1 diabetes. Ann Intern Med. 2001;134:729–36.

    Article  CAS  PubMed  Google Scholar 

  • Frohman L, Nagai K. Central nervous system-mediated stimulation of glucagon secretion in the dog following 2-deoxyglucose. Metabolism. 1976;25:1449–52.

    Article  CAS  PubMed  Google Scholar 

  • Fruehwald-Schultes B, Born J, Kern W, Peters A, Fehm HL. Adaptation of cognitive function to hypoglycemia in healthy men. Diabetes Care. 2000;23:1059–66.

    Article  CAS  PubMed  Google Scholar 

  • Frye RL, August P, Brooks MM, Hardison RM, Kelsey SF, MacGregor JM, Orchard TJ, Chaitman BR, Genuth SM, Goldberg SH, Hlatky MA, Jones TL, Molitch ME, Nesto RW, Sako EY, Sobel BE. A randomized trial of therapies for type 2 diabetes and coronary artery disease. N Engl J Med. 2009;360:2503–15.

    Article  CAS  PubMed  Google Scholar 

  • Galloway PJ, Thomson GA, Fisher BM, Semple CG. Insulin-induced hypoglycemia induces a rise in C-reactive protein. Diabetes Care. 2000;23:861–2.

    Article  CAS  PubMed  Google Scholar 

  • Geddes J, Schopman JE, Zammitt NN, Frier BM. Prevalence of impaired awareness of hypoglycemia in adults with type 1 diabetes. Diabet Med. 2008;25:501–4.

    Article  CAS  PubMed  Google Scholar 

  • Gerich J. Hypoglycemia and counterregulation in type 2 diabetes. Lancet. 2000;356:1946–7.

    Article  CAS  PubMed  Google Scholar 

  • Gerich JE. Hepatorenal glucose reciprocity in physiologic and pathologic conditions. Diabetes Nutr Metab. 2003;15:298–303.

    Google Scholar 

  • Gerich JE, Mokan M, Veneman T, Korytkowski M, Mitrakou A. Hypoglycemia unawareness. Endocr Rev. 1991;12:356–71.

    Article  CAS  PubMed  Google Scholar 

  • Gerstein HC, Miller ME, Byington RP, Goff DC Jr, Bigger JT, Buse JB, Cushman WC, Genuth S, Ismail-Beigi F, Grimm RH Jr, Probstfield JL, Simons-Morton DG, Friedewald WT. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med. 2008;358:2545–59.

    Article  CAS  PubMed  Google Scholar 

  • Gill GV, Woodward A, Casson IF, Weston PJ. Cardiac arrhythmia and nocturnal hypoglycemia in type 1 diabetes – the ‘dead in bed’ syndrome revisited. Diabetologia. 2009;52:42–5.

    Article  CAS  PubMed  Google Scholar 

  • Giorda CB, Ozzello A, Gentile S, Corsi A, Iannarelli R, Baccetti F, Lucisano G, Nicolucci A, Rossi MC. On behalf the HYPOS-1 study group incidence and correlates of hypoglycemia in type 2 diabetes. The Hypos-1 study. J Diabetes Metab. 2014;3:2–8.

    Google Scholar 

  • Giorda CB, Ozzello A, Gentile S, Aglialoro A, Chiambretti A, Baccetti F, Gentile FM, Lucisano G, Nicolucci A, Rossi MC, HYPOS-1 Study Group of AMD. Incidence and risk factors for severe and symptomatic hypoglycemia in type 1 diabetes. Results of the HYPOS-1 study. Acta Diabetol. 2015;52:845–53.

    Article  CAS  PubMed  Google Scholar 

  • Giorda CB, Rossi MC, Ozzello O, Gentile S, Aglialoro A, Chiambretti A, Baccetti F, Gentile FM, Romeo F, Lucisano G, Nicolucci A, HYPOS-1 Study Group of AMD. Healthcare resource use, direct and indirect costs of hypoglycemia in type 1 and type 2 diabetes, and nationwide projections. Results of the HYPOS-1 study. Nutr Metab Cardiovasc Dis. 2017;27:209–16.

    Article  CAS  PubMed  Google Scholar 

  • Gold AE, MacLeod KM, Frier BM. Frequency of severe hypoglycemia in patients with type I diabetes with impaired awareness of hypoglycemia. Diabetes Care. 1994;17:697–703.

    Article  CAS  PubMed  Google Scholar 

  • Gray CS, Hildreth AJ, Sandercock PA, O’Connell JE, Johnston DE, Cartlidge NE, Bamford JM, James OF, Alberti KG. Glucose-potassium-insulin infusions in the management of post-stroke hyperglycaemia: the UK Glucose Insulin in Stroke Trial (GIST-UK). Lancet Neurol. 2007;6:397–406.

    Article  CAS  PubMed  Google Scholar 

  • Green AJ, Fox KM, Grandy S, SHIELD Study Group. Self-reported hypoglycemia and impact on quality of life and depression among adults with type 2 diabetes mellitus. Diabetes Res Clin Pract. 2012;96:313–8.

    Article  PubMed  Google Scholar 

  • Gruetter R, Ugurbil K, Seaquist ER. Steady-state cerebral glucose concentrations and transport in the human brain. J Neurochem. 1998;70:397–408.

    Article  CAS  PubMed  Google Scholar 

  • Hammer M, Lammert M, Mejías SM, Kern W, Frier BM. Costs of managing severe hypoglycemia in three European countries. J Med Econ. 2009;12:281–90.

    Article  PubMed  Google Scholar 

  • Heller S, Cryer PE. Reduced neuroendocrine and symptomatic responses to subsequent hypoglycemia after one episodes of hypoglycemia in nondiabetic humans. Diabetes. 1991;40:223–6.

    Article  CAS  PubMed  Google Scholar 

  • Henderson JN, Allen KV, Deary IJ, Frier BM. Hypoglycemia in insulin-treated type 2 diabetes: frequency, symptoms and impaired awareness. Diabet Med. 2003;20:1016–21.

    Article  CAS  PubMed  Google Scholar 

  • Hepburn DA, MacLeod KM, Pell ACH, Scougal IJ, Frier BM. Frequency and symptoms of hypoglycemia experienced by patients with type 2 diabetes treated with insulin. Diabet Med. 1993;10:231–7.

    Article  CAS  PubMed  Google Scholar 

  • Hermansen K, Davies M, Derezinski T, Martinez Ravn G, Clauson P, Home P. A 26-week, randomized, parallel, treat-to-target trial comparing insulin detemir with NPH insulin as add-on therapy to oral glucose lowering drugs in insulin-naive people with type 2 diabetes. Diabetes Care. 2006;29:1269–74.

    Article  CAS  PubMed  Google Scholar 

  • Hershey T, Perantie DC, Warren SL, Zimmerman EC, Sadler M, White NH. Frequency and timing of severe hypoglycemia affects spatial memory in children with type 1 diabetes. Diabetes Care. 2005;28:2372–7.

    Article  PubMed  Google Scholar 

  • Hewitt J, Smeeth L, Chaturvedi N, Bulpitt CJ, Fletcher AE. Self management and patient understanding of diabetes in the older person. Diabet Med. 2011;28:117–22.

    Article  CAS  PubMed  Google Scholar 

  • Hopkins D, Lawrence I, Mansell P, Thompson G, Amiel S, Campbell M, Heller S. Improved biomedical and psychological outcomes 1 year after structured education in flexible insulin therapy for people with type 1 diabetes: the U.K. DAFNE experience. Diabetes Care. 2012;35:1638–42.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Hulkower RD, Pollack RM, Zonszein J. Understanding hypoglycemia in hospitalized patients. Diabetes Manag (Lond). 2014;4:165–76.

    Article  CAS  Google Scholar 

  • Hvidberg A, Fanelli CG, Hersbey T, Cryer PE. Impact of recent antecedent hypoglycemia on hypoglycemic cognitive dysfunction in nondiabetic humans. Diabetes. 1996;45:1030–26.

    Article  CAS  PubMed  Google Scholar 

  • International Hypoglycemia Study Group. Glucose concentrations of less than 3.0 mmol/L (54 mg/dL) should se seported in clinical trials: a joint position statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care. 2017;40:155–7.

    Article  CAS  Google Scholar 

  • Jaap AJ, Jones GC, McCrimmon RJ, Deary IJ, Frier BM. Perceived symptoms of hypoglycemia in elderly type 2 diabetic patients treated with insulin. Diabet Med. 1998;15:398–401.

    Article  CAS  PubMed  Google Scholar 

  • Johnston SS, Conner C, Aagren M, Smith DM, Bouchard J, Brett J. Evidence linking hypoglycemic events to an increased risk of acute cardiovascular events in patients with type 2 diabetes. Diabetes Care. 2011;34:1164–70.

    Article  PubMed  PubMed Central  Google Scholar 

  • Johnston SS, Conner C, Aagren M, Ruiz K, Bouchard J. Association between hypoglycemic events and fall-related fractures in medicare-covered patients with type 2 diabetes. Diabetes Obes Metab. 2012;14:634–43.

    Article  CAS  PubMed  Google Scholar 

  • Judson WE, Hollander W. The effects of insulin-induced hypoglycemia in patients with angina pectoris before and after intravenous hexamethonium. Am Heart J. 1956;52:198–209.

    Article  CAS  PubMed  Google Scholar 

  • Kosiborod M, Inzucchi SE, Krumholz HM, Xiao L, Jones PG, Fiske S, Masoudi FA, Marso SP, Spertus JA. Glucometrics in patients hospitalized with acute myocardial infarction: defining the optimal outcomes-based measure of risk. Circulation. 2008;117:1018–27.

    Article  CAS  PubMed  Google Scholar 

  • Laiteerapong N, Karter AJ, Liu JY, et al. Correlates of quality of life in older adults with diabetes: the diabetes & aging study. Diabetes Care. 2011;34:1749–53.

    Article  PubMed  PubMed Central  Google Scholar 

  • Laitinen T, Lyyra-Laitinen T, Huopio H, Vauhkonen I, Halonen T, Hartikainen J, Niskanen L, Laakso M. Electrocardiographic alterations during hyperinsulinemic hypoglycemia in healthy subjects. Ann Noninvasive Electrocardiol. 2008;13:97–105.

    Article  PubMed  PubMed Central  Google Scholar 

  • Leiter LA, Yale J-F, Chiasson JL, Harris S, Kleinstiver P, Sauriol L. Assessment of the impact of fear of hypoglycemic episodes on glycemic and hypoglycemia management. Can J Diabetes. 2005;29:186–92.

    Google Scholar 

  • Levin BE. Glucosensing neurons: the metabolic sensors of the brain? Diabetes Nutr Metab. 2002;15:274–80.

    CAS  PubMed  Google Scholar 

  • Little SA, Leelarathna L, Walkinshaw E, Tan HK, Chapple O, Lubina-Solomon A, Chadwick TJ, Barendse S, Stocken DD, Brennand C, Marshall SM, Wood R, Speight J, Kerr D, Flanagan D, Heller SR, Evans ML, Shaw JA. Recovery of hypoglycemia awareness in long-standing type 1 diabetes: a multicenter 2 × 2 factorial randomized controlled trial comparing insulin pump with multiple daily injections and continuous with conventional glucose self-monitoring (HypoCOMPaSS). Diabetes Care. 2014;37:2114–22.

    Article  CAS  PubMed  Google Scholar 

  • Lubow JM, Piñón IG, Avogaro A, Cobelli C, Treeson DM, Mandeville KA, Toffolo G, Boyle PJ. Brain oxygen utilization is unchanged by hypoglycemia in normal humans: lactate, alanine, and leucine uptake are not sufficient to offset energy deficit. Am J Physiol Endocrinol Metab. 2006;290:E149–53.

    Article  CAS  PubMed  Google Scholar 

  • Lucidi P, Porcellati F, Marinelli Andreoli A, Carriero I, Candeloro P, Cioli P, Bolli GB, Fanelli CG. Pharmacokinetics and pharmacodynamics of NPH insulin in type 1 diabetes: the importance of appropriate resuspension before subcutaneous injection. Diabetes Care. 2015;38:2204–10.

    Article  CAS  PubMed  Google Scholar 

  • Lundkvist J, Berne C, Bolinder B, Jönsson L. The economic and quality of life impact of hypoglycemia. Eur J Health Econ. 2005;6:197–202.

    Article  PubMed  Google Scholar 

  • Ly TT, Hewitt J, Davey RJ, Lim EM, Davis EA, Jones TW. Improving epinephrine responses in hypoglycemia unawareness with real-time continuous glucose monitoring in adolescents with type 1 diabetes. Diabetes Care. 2011;34:50–2.

    Article  PubMed  Google Scholar 

  • Ly TT, Nicholas JA, Retterath A, Lim RM, Davis EA, Jones TW. Effect of sensor-augmented insulin pump therapy and automated insulin suspension vs standard insulin pump therapy on hypoglycemia in patients with type 1 diabetes. JAMA. 2013;310:1240–7.

    Article  CAS  PubMed  Google Scholar 

  • Ly TT, Maahs DM, Rewers A, Dunger D, Oduwole A, Jones TW. ISPAD Clinical Practice Consensus Guidelines – Hypoglycemia: assessment and management of hypoglycemia in children and adolescents with diabetes. Pediatr Diabetes. 2014;15(Suppl 20):180–92.

    Article  CAS  PubMed  Google Scholar 

  • Marchesini G, Veronese G, Forlani G, Ricciardi LM, Italian Society of Emergency Medicine SIMEU. The management of severe hypoglycemia by the emergency system: the HYPOTHESIS study. Nutr Metab Cardiovasc Dis. 2014;24:1181–8.

    Article  CAS  PubMed  Google Scholar 

  • Matyka K, Evans M, Lomas J, Cranston I, Macdonald I, Amiel SA. Altered hierarchy of protective responses against severe hypoglycemia in normal aging in healthy men. Diabetes Care. 1997;20:135–41.

    Article  CAS  PubMed  Google Scholar 

  • McCall A, Fixman L, Fleming N, Tornheim K, Click W, Ruderman NB. Chronic hypoglycemia increases brain glucose transport. Am J Phys. 1986;251:E442–7.

    CAS  Google Scholar 

  • McCoy RG, Van Houten HK, Ziegenfuss JY, Shah ND, Wermers RA, Smith SA. Increased mortality of patients with diabetes reporting severe hypoglycemia. Diabetes Care. 2012;35:1897–901.

    Article  PubMed  PubMed Central  Google Scholar 

  • Mellbin LG, Malmberg K, Waldenstrom A, Wedel H, Ryden L. Prognostic implications of hypoglycemic episodes during hospitalisation for myocardial infarction in patients with type 2 diabetes: a report from the DIGAMI 2 trial. Heart. 2009;95:721–7.

    Article  CAS  PubMed  Google Scholar 

  • Meneilly GS, Cheung E, Tuokko H. Altered responses to hypoglycemia of healthy elderly people. J Clin Endocrinol Metab. 1994;78:1341–8.

    CAS  PubMed  Google Scholar 

  • Meyer C, Nadkarni V, Stumvoll M, Gerich J. Human kidney free fatty acid and glucose uptake: evidence for a renal glucosefatty acid cycle. Am J Phys. 1997;273:E650–4.

    CAS  Google Scholar 

  • Mitrakou A, Ryan C, Veneman T, Mokan M, Jenssen T, Kiss I, Durrant J, Cryer P, Gerich J. Hierarchy of glycemic thresholds for counterregulatory hormone secretion, symptoms, and cerebral dysfunction. Am J Phys. 1991;260:E67–74.

    Article  CAS  Google Scholar 

  • Mitrakou A, Fanelli C, Veneman T, Perriello G, Calderone S, Platanisiotis D, Rambotti A, Raptis S, Brunetti P, Cryer P, Bolli GB. Reversibility of unawareness of hypoglycemia in patients with insulinomas. N Engl J Med. 1993;329:834–9.

    Article  CAS  PubMed  Google Scholar 

  • Monami M, Dicembrini I, Kundisova L, Zannoni S, Nreu B, Mannucci E. A meta-analysis of the hypoglycemic risk in randomized controlled trials with sulfonylureas in patients with type 2 diabetes. Diabetes Obes Metab. 2014;16:833–40.

    Article  CAS  PubMed  Google Scholar 

  • Monnier L, Lapinski H, Colette C. Contributions of fasting and postprandial plasma glucose increments to the overall diurnal hyperglycemia of type 2 diabetic patients: variations with increasing levels of HbA(1c). Diabetes Care. 2003;26:881–5.

    Article  PubMed  Google Scholar 

  • Nathan DM, Buse JB, Davidson MB, Ferrannini E, Holman RR, Sherwin R, Zinman B, American Diabetes Association, European Association for Study of Diabetes. Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care. 2009;32:193–203.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Olsen SE, Asvold BO, Frier BM, Aune SE, Hansen LI, Bjørgaas MR. Hypoglycemia symptoms and impaired awareness of hypoglycemia in adults with type 1 diabetes: the association with diabetes duration. Diabet Med. 2014;31:1210–7.

    Article  CAS  PubMed  Google Scholar 

  • Östenson CG, Geelhoed-Duijvestijn P, Lahtela J, Weitgasser R, Markert Jensen M, Pedersen-Bjergaard U. Self-reported non-severe hypoglycemic events in Europe. Diabet Med. 2014;31:92–101.

    Article  PubMed  Google Scholar 

  • Ovalle F, Fanelli CG, Paramore DS, Hershey T, Craft S, Cryer PE. Brief twice-weekly episodes of hypoglycemia reduce detection of clinical hypoglycemia in type 1 diabetes mellitus. Diabetes. 1998;47:1472–9.

    Article  CAS  PubMed  Google Scholar 

  • Owen OE, Felig P, Morgan AP, Wahren J, Cahill GF Jr. Liver and kidney metabolism during prolonged starvation. J Clin Invest. 1969;48:574–83.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Owens DR, Zinman B, Bolli GB. Insulins today and beyond. Lancet. 2001;358:739–46.

    Article  CAS  PubMed  Google Scholar 

  • Öz G, Kumar A, Rao JP, Kodl CT, Chow L, Eberly LE, Seaquist ER. Human brain glycogen metabolism during and after hypoglycemia. Diabetes. 2009;58:1978–85.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Öz G, Tesfaye N, Kumar A, Deelchand DK, Eberly LE, Seaquist ER. Brain glycogen content and metabolism in subjects with type 1 diabetes and hypoglycemia unawareness. J Cereb Blood Flow Metab. 2012;32:256–63.

    Article  PubMed  CAS  Google Scholar 

  • Öz G, DiNuzzo M, Kumar A, Moheet A, Seaquist ER. Revisiting glycogen content in the human brain. Neurochem Res. 2015;40:2473–81.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Paranjape SA, Chan O, Zhu W, Horblitt AM, McNay EC, Cresswell JA, Bogan JS, McCrimmon RJ, Sherwin RS. Influence of insulin in the ventromedial hypothalamus on pancreatic glucagon secretion in vivo. Diabetes. 2010;59:1521–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Patel A, MacMahon S, Chalmers J, Neal B, Billot L, Woodward M, Marre M, Cooper M, Glasziou P, Grobbee D, Hamet P, Harrap S, Heller S, Liu L, Mancia G, Mogensen CE, Pan C, Poulter N, Rodgers A, Williams B, Bompoint S, de Galan BE, Joshi R, Travert F. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med. 2008;358:2560–72.

    Article  CAS  PubMed  Google Scholar 

  • Pedersen-Bjergaard U, Pramming S, Heller SR, Wallace TM, Rasmussen AK, Jørgensen HV, Matthews DR, Hougaard P, Thorsteinsson B. Severe hypoglycemia in 1076 adult patients with type 1 diabetes: influence of risk markers and selection. Diabetes Metab Res Rev. 2004;20:479–86.

    Article  PubMed  Google Scholar 

  • Pinto DS, Skolnick AH, Kirtane AJ, Murphy SA, Barron HV, Giugliano RP, Cannon CP, Braunwald E, Gibson CM. U-shaped relationship of blood glucose with adverse outcomes among patients with ST-segment elevation myocardial infarction. J Am Coll Cardiol. 2005;46:178–80.

    Article  CAS  PubMed  Google Scholar 

  • Porcellati F, Lucidi P, Bolli GB, Fanelli CG. GLP-1 RAs as compared to prandial insulin after failure of basal insulin in type 2 diabetes: lessons from the 4B and Get-Goal DUO 2 trials. Diabetes Metab. 2015;41(6 Suppl 1):6S16–20.

    Article  CAS  PubMed  Google Scholar 

  • Razavi Nematollahi L, Kitabchi AE, Stentz FB, Wan JY, Larijani BA, Tehrani MM, Gozashti MH, Omidfar K, Taheri E. Proinflammatory cytokines in response to insulin-induced hypoglycemic stress in healthy subjects. Metabolism. 2009;58:443–8.

    Article  CAS  PubMed  Google Scholar 

  • Reichard P, Nilsson B-Y, Rosenquist U. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993;329:304–9.

    Article  CAS  PubMed  Google Scholar 

  • Riddle MC, Rosenstock J, Gerich J. The treat-to-target trial: randomized addition of glargine or human NPH insulin to oral therapy of type 2 diabetic patients. Diabetes Care. 2003;26:3080–6.

    Article  CAS  PubMed  Google Scholar 

  • Ritter R, Slusser P, Stone S. Glucoreceptors controlling feeding and blood glucose: location in the hindbrain. Science. 1981;213:451–2.

    Article  CAS  PubMed  Google Scholar 

  • Robinson RT, Harris ND, Ireland RH, Lee S, Newman C, Heller SR. Mechanisms of abnormal cardiac repolarization during insulin-induced hypoglycemia. Diabetes. 2003;52:1469–74.

    Article  CAS  PubMed  Google Scholar 

  • Rooijackers HM, Wiegers EC, Tack CJ, van der Graaf M, de Galan BE. Brain glucose metabolism during hypoglycemia in type 1 diabetes: insights from functional and metabolic neuroimaging studies. Cell Mol Life Sci. 2016;73:705–22.

    Article  CAS  PubMed  Google Scholar 

  • Rossetti P, Porcellati F, Busciantella Ricci N, Candeloro P, Cioli P, Nair KS, Santeusanio F, Bolli GB, Fanelli CG. Effect of oral amino acids on counterregulatory responses and cognitive function during insulin-induced hypoglycemia in nondiabetic and type 1 diabetic people. Diabetes. 2008a;57:1905–17.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Rossetti P, Porcellati F, Bolli GB, Fanelli CG. Prevention of hypoglycemia while achieving good glycemic control in type 1 diabetes. Diabetes Care. 2008b;31(Suppl 2):S113–20.

    Article  CAS  PubMed  Google Scholar 

  • Routh VH. Glucose-sensing neurons: are they physiologically relevant? Physiol Behav. 2002;76:403–13.

    Article  CAS  PubMed  Google Scholar 

  • Routh VH. Glucosensing neurons in the ventromedial hypothalamic nucleus (VMN) and hypoglycemia-associated autonomic failure (HAAF). Diabetes Metab Res Rev. 2003;19:348–56.

    Article  CAS  PubMed  Google Scholar 

  • Routh VH. Glucose sensing neurons in the ventromedial hypothalamus. Sensors (Basel). 2010;10:9002–25.

    Article  CAS  Google Scholar 

  • Samuel S, Goswami D, Shum K, Boye KS, Rengarajan B, et al. A model of mild hypoglycemia. Curr Med Res Opin. 2015;31:633–41.

    Article  CAS  PubMed  Google Scholar 

  • Seaquist ER, Miller ME, Bonds DE, Feinglos M, Goff DC Jr, Peterson K, Senior P, ACCORD Investigators. The impact of frequent and unrecognized hypoglycemia on mortality in the ACCORD study. Diabetes Care. 2012;35:409–14.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Seaquist ER, Anderson J, Childs B, Cryer P, Dagogo-Jack S, Fish L, Heller SR, Rodriguez H, Rosenzweig J, Vigersky R. Hypoglycemia and diabetes: a report of a workgroup of the American Diabetes Association and the Endocrine Society. Diabetes Care. 2013;36:1384–95.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Segel SA, Paramore DS, Cryer PE. Hypoglycemia-associated autonomic failure in advanced type 2 diabetes. Diabetes. 2002;51:724–33.

    Article  CAS  PubMed  Google Scholar 

  • Shichiri M, Kishikawa H, Ohkubo Y, Wake N. Long term results of the Kumamoto study on optimal diabetes control in type 2 diabetic patients. Diabetes Care. 2000;23:B21–9.

    PubMed  Google Scholar 

  • Shimazu T, Fukuda A, Ban T. Reciprocal influence of the ventro-medial and lateral hypothalamic nuclei on blood glucose level and liver glycogen content. Nature. 1966;210:1178–9.

    Article  CAS  PubMed  Google Scholar 

  • Shorr RI, Ray WA, Daugherty JR, Griffin MR. Individual sulfonylureas and serious hypoglycemia in older people. J Am Geriatr Soc. 1996;44:751–5.

    Article  CAS  PubMed  Google Scholar 

  • Skyler JS, Bergenstal R, Bonow RO, Buse J, Deedwania P, Gale EA, Howard BV, Kirkman MS, Kosiborod M, Reaven P, Sherwin RS. Intensive glycemic control and the prevention of cardiovascular events: implications of the ACCORD, ADVANCE, and VA Diabetes Trials: a position statement of the American Diabetes Association and a Scientific Statement of the American College of Cardiology Foundation and the American Heart Association. J Am Coll Cardiol. 2009;53:298–304.

    Article  PubMed  Google Scholar 

  • Sommerfield AJ, Wilkinson IB, Webb DJ, Frier BM. Vessel wall stiffness in type 1 diabetes and the central hemodynamic effects of acute hypoglycemia. Am J Physiol Endocrinol Metab. 2007;293:E1274–9.

    Article  CAS  PubMed  Google Scholar 

  • Song Z, Levin BE, McArdle JJ, Bakhos N, Routh VH. Convergence of pre- and postsynaptic influences on glucosensing neurons in the ventromedial hypothalamic nucleus. Diabetes. 2001;50:2673–81.

    Article  CAS  PubMed  Google Scholar 

  • Spyer G, Hattersley A, MacDonald I, Amiel S, MacLeod H. Hypoglycemic counter-regulation at normal blood glucose concentrations in patients with well controlled type-2 diabetes. Lancet. 2000;356:1970–4.

    Article  CAS  PubMed  Google Scholar 

  • Stumvoll M, Chintalapudi U, Perriello G, Welle S, Gutierrez O, Gerich J. Uptake and release of glucose by the human kidney: postabsorptive rates and responses to epinephrine. J Clin Invest. 1995;96:2528–33.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Stumvoll M, Meyer C, Kreider M, Perriello G, Gerich J. Effects of glucagon on renal and hepatic glutamine gluconeogenesis in normal postabsorptive humans. Metabolism. 1998a;47: 1227–732.

    Article  CAS  PubMed  Google Scholar 

  • Stumvoll M, Meyer C, Perriello G, Kreider M, Welle S, Gerich J. Human kidney and liver gluconeogenesis: evidence for organ substrate selectivity. Am J Phys. 1998b;274:E817–26.

    CAS  Google Scholar 

  • Szoke E, Gosmanov NR, Sinkin JC, Nihalani A, Fender AB, Cryer PE, Meyer C, Gerich JE. Effects of glimepiride and glyburide on glucose counterregulation and recovery from hypoglycemia. Metabolism. 2006;55:78–83.

    Article  CAS  PubMed  Google Scholar 

  • Tattersall RB, Gill GV. Unexplained deaths of type 1 diabetic patients. Diabet Med. 1991;8:49–58.

    Article  CAS  PubMed  Google Scholar 

  • The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993;329:977–86.

    Article  Google Scholar 

  • The UKPDS Research Group. Overview of 6 years of therapy of type II diabetes: a progressive disease. Diabetes. 1995;44:1249–58.

    Article  Google Scholar 

  • Towler DA, Havlin CE, Craft S, Cryer P. Mechanism of awareness of hypoglycemia. Perception of neurogenic (predominantly cholinergic) rather than neuroglycopenic symptoms. Diabetes. 1993;42:1791–8.

    Article  CAS  PubMed  Google Scholar 

  • Uehara Y, Nipper V, McCall AL. Chronic insulin hypoglycemia induces GLUT-3 protein in rat brain neurons. Am J Phys. 1997;272:E716–9.

    CAS  Google Scholar 

  • UK Hypoglycemia Study Group. Risk of hypoglycemia in types 1 and 2 diabetes: effects of treatment modalities and their duration. Diabetologia. 2007;50:1140–7.

    Article  CAS  Google Scholar 

  • UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulfonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet. 1998;352:837–53.

    Article  Google Scholar 

  • van de Ven KC, van der Graaf M, Tack CJ, Heerschap A, de Galan BE. Steady-state brain glucose concentrations during hypoglycemia in healthy humans and patients with type 1 diabetes. Diabetes. 2012;61:1974–7.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Vannucci SJ, Maher F, Simpson IA. Glucose transporter proteins in brain: delivery of glucose to neurons and glia. Glia. 1997;21:2–21.

    Article  CAS  PubMed  Google Scholar 

  • Veneman T, Mitrakou A, Mokan M, Cryer P, Gerich JE. Induction of hypoglycemia unawareness by asymptomatic nocturnal hypoglycemia. Diabetes. 1993;42:1233–7.

    Article  CAS  PubMed  Google Scholar 

  • Veronese G, Marchesini G, Forlani G, Saragoni S, Degli Esposti L, et al. Costs associated with emergency care and hospitalization for severe hypoglycemia. Nutr Metab Cardiovasc Dis. 2016;26:345–51.

    Article  CAS  PubMed  Google Scholar 

  • Vlcek M, Radikova Z, Penesova A, Kvetnansky R, Imrich R. Heart rate variability and catecholamines during hypoglycemia and orthostasis. Auton Neurosci. 2008;143:53–7.

    Article  CAS  PubMed  Google Scholar 

  • Wender R, Brown AM, Fern R, Swanson RA, Farrell K, Ransom BR. Astrocytic glycogen influences axon function and survival during glucose deprivation in central white matter. J Neurosci. 2000;20:6804–10.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Weng J, Li Y, Xu W, Shi L, Zhang Q, Zhu D, Hu Y, Zhou Z, Yan X, Tian H, Ran X, Luo Z, Xian J, Yan L, Li F, Zeng L, Chen Y, Yang L, Yan S, Liu J, Li M, Fu Z, Cheng H. Effect of intensive insulin therapy on beta-cell function and glycaemic control in patients with newly diagnosed type 2 diabetes: a multicentre randomised parallel-group trial. Lancet. 2008;371:1753–60.

    Article  CAS  PubMed  Google Scholar 

  • White NH, Skor DA, Cryer PE, Levandoski LA, Bier DM, Santiago JV. Identification of type I diabetic patients at increased risk for hypoglycemia during intensive therapy. N Engl J Med. 1983;308:485–91.

    Article  CAS  PubMed  Google Scholar 

  • Whitmer RA, Karter AJ, Yaffe K, Quesenberry CP Jr, Selby JV. Hypoglycemic episodes and risk of dementia in older patients with type 2 diabetes mellitus. JAMA. 2009;301:1565–72.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Woerle HJ, Meyer C, Popa EM, Cryer PE, Gerich JE. Renal compensation for impaired hepatic glucose release during hypoglycemia in type 2 diabetes: further evidence for hepatorenal reciprocity. Diabetes. 2003;52:1386–92.

    Article  CAS  PubMed  Google Scholar 

  • Woo VC. A review of the clinical efficacy and safety of insulin Degludec and Glargine 300 U/mL in the treatment of diabetes mellitus. Clin Ther. 2017;39:S12–33. pii: S0149-2918(17)30040-1.

    Article  CAS  PubMed  Google Scholar 

  • Workgroup on Hypoglycemia, American Diabetes Association. Defining and reporting hypoglycemia in diabetes: a report from the American Diabetes Association Workgroup on Hypoglycemia. Diabetes Care. 2005;28:1245–9.

    Article  Google Scholar 

  • Wysham CH, Lin J, Kuritzky L. Safety and efficacy of a glucagon-like peptide-1 receptor agonist added to basal insulin therapy versus basal insulin with or without a rapid-acting insulin in patients with type 2 diabetes: results of a meta-analysis. Postgrad Med. 2017;15:1–10.

    Google Scholar 

  • Yaffe K, Falvey CM, Hamilton N, Harris TB, Simonsick EM, Strotmeyer ES, Shorr RI, Metti A, Schwartz AV, Health ABC Study. Association between hypoglycemia and dementia in a biracial cohort of older adults with diabetes mellitus. JAMA Intern Med. 2013;173:1300–6.

    Article  PubMed  PubMed Central  Google Scholar 

  • Yeoh E, Choudhary P, Nwokolo M, Ayis S, Amiel SA. Interventions that restore awareness of hypoglycemia in adults with type 1 diabetes: a systematic review and meta-analysis. Diabetes Care. 2015;38:1592–609.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Geremia B. Bolli .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer International Publishing AG, part of Springer Nature

About this entry

Check for updates. Verify currency and authenticity via CrossMark

Cite this entry

Fanelli, C.G., Lucidi, P., Bolli, G.B., Porcellati, F. (2018). Hypoglycemia. In: Bonora, E., DeFronzo, R. (eds) Diabetes Complications, Comorbidities and Related Disorders. Endocrinology. Springer, Cham. https://doi.org/10.1007/978-3-319-44433-8_22

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-44433-8_22

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-44432-1

  • Online ISBN: 978-3-319-44433-8

  • eBook Packages: MedicineReference Module Medicine

Publish with us

Policies and ethics